Middle East and Africa Infectious Disease Diagnostics Market Forecast to 2028

Middle East and Africa Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and Point of Care Testing), Disease Indication (HIV, Hepatitis, Healthcare-Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others), and End User (Hospitals and Clinics, Pathology/Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others)

Report Code : BMIRE00025322 | Region : LAMEA | Industry : Biotechnology | Published Date : 12/Jul/2022

The MEA infectious disease diagnostics market is expected to grow from US$ 1,074.80 million in 2021 to US$ 1,607.38 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028.

There are many small and big companies in the infectious disease diagnostics market. Market players are adopting various strategies to increase market shares, such as new product launches, regional expansion, and technological advancements. Infectious disease diagnostics are safer and more effective with continued innovation and technological advances. Therefore, the acceptance of infectious disease diagnostics is increasing. For instance, in May 2021, Torus Biosystems launched the US$ 25 million series of funding to advance infectious disease diagnostics across healthcare settings. Further, in December 2021, in countries that accept the CE mark, Roche launched the first infectious illness tests on the Cobas 5800 System, a new molecular laboratory instrument. Cobas HBV, Cobas HCV, Cobas HIV-1, Cobas HIV-1/HIV-2 Qualitative, and the Cobas Omni Utility Channel kit are a few of these options. Similarly, in June 2021, Bio-Rad Laboratories, Inc. launched its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, an accurate, sensitive, and cost-effective tool used to detect SARS-CoV-2 in a community’s wastewater. The active participation of players in product innovation and development and an increase in product approvals are likely to boost the growth of the infectious disease diagnostics market during the forecast period.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA infectious disease diagnostics market at a notable CAGR during the forecast period.

MEA Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

MEA Infectious Disease Diagnostics Market Segmentation

The MEA infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the MEA infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the MEA infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the MEA infectious disease diagnostics market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare are among the leading companies operating in the MEA infectious disease diagnostics market.

Immunodiagnostics Segment to Dominate MEA Infectious Disease Diagnostics Market During 2021–2028

According to a new market research study on “MEA Infectious Disease Diagnostics Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Technology, Testing Type, Disease Indication and End User ” is expected to reach US$ 1,607.38 million by 2028 from US$ 1,074.80 million in 2021. The market is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report provides trends prevailing in the MEA infectious disease diagnostics market along with the drivers and restraints pertaining to the market growth. Rising number of product approvals and launches is the major factor driving the growth of the MEA infectious disease diagnostics market . However, inadequate reimbursement scenario may hamper the growth of the market hinders the growth of MEA infectious disease diagnostics market .

The MEA infectious disease diagnostics market is analyzed based on product, technology, testing type, disease indication and end user, and country. Based on product, the MEA infectious disease diagnostics market, has been segmented into kits and reagents, instruments, and software and services. The kits and reagents segment dominated the market in 2020 and software and services segment is expected to be fastest growing during forecast period. Based on technology, the market is segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on testing type, the market is segmented into laboratory testing and point of care testing. The laboratory testing segment dominated the market in 2020 and point of care testing segment is expected to be fastest growing during forecast period. Based on disease indication, the market is segmented into HIV, Hepatitis, Healthcare Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others. The hepatitis segment dominated the market in 2020 and healthcare- associated infections (HAIs) segment is expected to be fastest growing during forecast period. Based on end user, the MEA infectious disease diagnostics market, has been segmented into hospitals and clinics, pathology/ diagnostic laboratories, research institutes, home care settings, and others. The pathology/ diagnostic laboratories segment dominated the market in 2020 and home care settings segment is expected to be fastest growing during forecast period. Based on country, the MEA infectious disease diagnostics market is segmented into Saudi Arabia, UAE, South Africa, and Rest of MEA.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare among the leading companies in the MEA infectious disease diagnostics market . The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, CerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/CE). The molecular test for detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Infectious Disease Diagnostics Market – By Product

1.3.2 MEA Infectious Disease Diagnostics Market – By Technology

1.3.3 MEA Infectious Disease Diagnostics Market – By Testing Type

1.3.4 MEA Infectious Disease Diagnostics Market – By Disease Indication

1.3.5 MEA Infectious Disease Diagnostics Market – By End User

1.3.6 MEA Infectious Disease Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Infectious Disease Diagnostics Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Experts Opinion

5. MEA Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Infectious Disease

5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Growing Opportunities in Developing Nations

5.4 Future Trend

5.4.1 Rising Number of Product Approvals and Launches

5.5 Impact Analysis

6. Infectious Disease Diagnostics Market– MEA Analysis

6.1 MEA Infectious Disease Diagnostics Market Revenue Forecast and Analysis

7. MEA Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 MEA by Product: Market Revenue and Forecast Analysis (US$ Million)

7.3 Kits and Reagents

7.3.1 Overview

7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)

8. MEA Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology

8.1 MEA Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

8.2 Immunodiagnostics

8.2.1 Overview

8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Next Generation Sequencing

8.4.1 Overview

8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Clinical Microbiology

8.5.1 Overview

8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type

9.1 MEA Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

9.2 Laboratory Testing

9.2.1 Overview

9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Point of Care Testing

9.3.1 Overview

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication

10.1 Overview

10.2 MEA Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Hepatitis

10.4.1 Overview

10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Healthcare Associated Infections (HAIs)

10.5.1 Overview

10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

10.6 Human Papillomavirus (HPV)

10.6.1 Overview

10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

10.7 Tuberculosis (TB)

10.7.1 Overview

10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

10.8 Influenza

10.8.1 Overview

10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. MEA Infectious Disease Diagnostics Market Analysis – by End User

11.1 Overview

11.2 MEA Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

11.3 Hospitals and Clinics

11.3.1 Overview

11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Pathology or Diagnostic Laboratories

11.4.1 Overview

11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Research Institutes

11.5.1 Overview

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Home Care Settings

11.6.1 Overview

11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12. MEA Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis

12.1 MEA: Infectious Disease Diagnostics Market

12.1.1 Overview

12.1.3 MEA: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.1.3.1 Saudi Arabia: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.1.3.1.1 Saudi Arabia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.2 Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.1.3.1.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.1.3.1.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.1.3.1.6 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.1.3.2 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.1 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.2 UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.3 UAE: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.1.3.2.4 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.1.3.2.5 UAE: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.1.3.2.6 UAE: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.1.3.3 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.1 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.2 South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.3 South Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.1.3.3.4 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.1.3.3.5 South Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.1.3.3.6 South Africa: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.1.3.4 Rest of MEA: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.1.3.4.1 Rest of MEA: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.1.3.4.2 Rest of MEA Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.1.3.4.3 Rest of MEA: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.1.3.4.4 Rest of MEA: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.1.3.4.5 Rest of MEA: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.1.3.4.6 Rest of MEA: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 Danaher

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Abbott

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 BD

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Trinity Biotech

14.4.1 1.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 F. HOFFMANN-LA ROCHE LTD.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Cardinal Health Inc.

14.6.1 1.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 bioMerieux SA

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 BIO-RAD LABORATORIES INC.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AccuBioTech Co., Ltd.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 ACON Laboratories, Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

LIST OF TABLES.

Table 1.             MEA Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Table 2.             Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 8.             UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 9.             UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          UAE Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 14.          South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          South Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 16.          South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of MEA Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of MEA Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of MEA Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of MEA Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of MEA Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 22.          Organic Developments Done By Companies

Table 23.          Inorganic Developments Done By Companies

Table 24.          Glossary of Terms

LIST OF FIGURES.

Figure 1.           MEA Infectious Disease Diagnostics Market Segmentation

Figure 2.           MEA Infectious Disease Diagnostics Market, By Country

Figure 3.           MEA Infectious Disease Diagnostics Market Overview

Figure 4.           MEA Infectious Disease Diagnostics Market, by Product

Figure 5.           MEA Infectious Disease Diagnostics Market, by Country

Figure 6.           MEA: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           MEA Infectious Disease Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           MEA Infectious Disease Diagnostics Market– Revenue Forecast and Analysis

Figure 10.        MEA by Product: Market Analysis and Forecast 2021 and 2028 (%)

Figure 11.        MEA Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        MEA Instruments Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Software and Services Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        MEA Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

Figure 15.        MEA Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        MEA Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

Figure 21.        MEA Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        MEA Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

Figure 24.        MEA HIV Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        MEA Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        MEA Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        MEA Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        MEA Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        MEA Influenza Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        MEA Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        MEA Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

Figure 32.        MEA Hospitals: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        MEA Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        MEA Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        MEA Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        MEA Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        MEA: Infectious Disease Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 38.        MEA: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 39.        Saudi Arabia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.        Rest of MEA: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

The List of Companies - Middle East and Africa Infectious Disease Diagnostics Market

● Abbott

● AccuBioTech Co., Ltd.

● ACON Laboratories, Inc.

● BD

● bioMerieux SA

● BIO-RAD LABORATORIES INC.

● Cardinal Health Inc

● Danaher

● F. HOFFMANN-LA ROCHE LTD.

● Trinity Biotech

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA infectious disease diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the MEA infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP